About Us Services Careers FAQ Contact Us 0
Home Medical Devices Novel Drug Delivery System Market Demand, Share, Forecast to 2030
Novel Drug Delivery System Market

Novel Drug Delivery System Market Size, Share & Trends Analysis Report By Route of Administration (Oral Drug, Injectable Drug, Pulmonary Drug, Transdermal Drug, Others), By Mode of NDSS (Targeted, Controlled, Modulated) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRMD2648DR
Last Updated : September 20, 2022
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Novel Drug Delivery System Market Introduction
    2. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drug
        1. By Value
      3. Injectable Drug
        1. By Value
      4. Pulmonary Drug
        1. By Value
      5. Transdermal Drug
        1. By Value
      6. Others
        1. By Value
    3. By Mode of NDSS
      1. Introduction
        1. Mode of NDSS By Value
      2. Targeted
        1. By Value
      3. Controlled
        1. By Value
      4. Modulated
        1. By Value
    1. Introduction
    2. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drug
        1. By Value
      3. Injectable Drug
        1. By Value
      4. Pulmonary Drug
        1. By Value
      5. Transdermal Drug
        1. By Value
      6. Others
        1. By Value
    3. By Mode of NDSS
      1. Introduction
        1. Mode of NDSS By Value
      2. Targeted
        1. By Value
      3. Controlled
        1. By Value
      4. Modulated
        1. By Value
    4. U.S.
      1. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drug
          1. By Value
        3. Injectable Drug
          1. By Value
        4. Pulmonary Drug
          1. By Value
        5. Transdermal Drug
          1. By Value
        6. Others
          1. By Value
      2. By Mode of NDSS
        1. Introduction
          1. Mode of NDSS By Value
        2. Targeted
          1. By Value
        3. Controlled
          1. By Value
        4. Modulated
          1. By Value
    5. Canada
    1. Introduction
    2. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drug
        1. By Value
      3. Injectable Drug
        1. By Value
      4. Pulmonary Drug
        1. By Value
      5. Transdermal Drug
        1. By Value
      6. Others
        1. By Value
    3. By Mode of NDSS
      1. Introduction
        1. Mode of NDSS By Value
      2. Targeted
        1. By Value
      3. Controlled
        1. By Value
      4. Modulated
        1. By Value
    4. U.K.
      1. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drug
          1. By Value
        3. Injectable Drug
          1. By Value
        4. Pulmonary Drug
          1. By Value
        5. Transdermal Drug
          1. By Value
        6. Others
          1. By Value
      2. By Mode of NDSS
        1. Introduction
          1. Mode of NDSS By Value
        2. Targeted
          1. By Value
        3. Controlled
          1. By Value
        4. Modulated
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drug
        1. By Value
      3. Injectable Drug
        1. By Value
      4. Pulmonary Drug
        1. By Value
      5. Transdermal Drug
        1. By Value
      6. Others
        1. By Value
    3. By Mode of NDSS
      1. Introduction
        1. Mode of NDSS By Value
      2. Targeted
        1. By Value
      3. Controlled
        1. By Value
      4. Modulated
        1. By Value
    4. China
      1. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drug
          1. By Value
        3. Injectable Drug
          1. By Value
        4. Pulmonary Drug
          1. By Value
        5. Transdermal Drug
          1. By Value
        6. Others
          1. By Value
      2. By Mode of NDSS
        1. Introduction
          1. Mode of NDSS By Value
        2. Targeted
          1. By Value
        3. Controlled
          1. By Value
        4. Modulated
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drug
        1. By Value
      3. Injectable Drug
        1. By Value
      4. Pulmonary Drug
        1. By Value
      5. Transdermal Drug
        1. By Value
      6. Others
        1. By Value
    3. By Mode of NDSS
      1. Introduction
        1. Mode of NDSS By Value
      2. Targeted
        1. By Value
      3. Controlled
        1. By Value
      4. Modulated
        1. By Value
    4. UAE
      1. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drug
          1. By Value
        3. Injectable Drug
          1. By Value
        4. Pulmonary Drug
          1. By Value
        5. Transdermal Drug
          1. By Value
        6. Others
          1. By Value
      2. By Mode of NDSS
        1. Introduction
          1. Mode of NDSS By Value
        2. Targeted
          1. By Value
        3. Controlled
          1. By Value
        4. Modulated
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drug
        1. By Value
      3. Injectable Drug
        1. By Value
      4. Pulmonary Drug
        1. By Value
      5. Transdermal Drug
        1. By Value
      6. Others
        1. By Value
    3. By Mode of NDSS
      1. Introduction
        1. Mode of NDSS By Value
      2. Targeted
        1. By Value
      3. Controlled
        1. By Value
      4. Modulated
        1. By Value
    4. Brazil
      1. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drug
          1. By Value
        3. Injectable Drug
          1. By Value
        4. Pulmonary Drug
          1. By Value
        5. Transdermal Drug
          1. By Value
        6. Others
          1. By Value
      2. By Mode of NDSS
        1. Introduction
          1. Mode of NDSS By Value
        2. Targeted
          1. By Value
        3. Controlled
          1. By Value
        4. Modulated
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Novel Drug Delivery System Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AstraZeneca PLC
    3. Bayer AG.
    4. Hoffmann-La Roche AG
    5. GlaxoSmithKline PLC
    6. Johnson & Johnson
    7. Merck & Co. Inc.
    8. Novartis AG
    9. Pfizer Inc.
    10. Sanofi SA.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Drone Package Delivery System Market Size The global drone package delivery system market size is estimated to be worth USD 477.48 million in 2024. It is projected to reach from USD 659.88 million in 2025 to USD 8780.69 million by 2033, growing at a
Buy Now
Global Report
The Total Addressable Market (TAM) for Novel Vaccine Delivery System was valued at USD 5.41 billion in 2021. It is projected to reach USD 13.29 billion by 2030, growing at a CAGR of 10.5% during the forecast period (2022-2030).  Vaccines, also
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.